Host Morgan Sung talks with UCSF dermatologist Dr. Sungat Grewal, who warns of real risks from the unapproved Barbie peptide, plus STAT's Sarah Todd on MAHA.
Recap by typeshit. Full story at KQED.
The Form 483 cites microbial growth in a clean hood, reversed cleanroom air pressure and active ingredients marked for research use only. Check which pharmacy filled your vial.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
The Washington Post reports the administration is clearing a path for certain unapproved peptides to be sold for a limited time.
Metabolic scientist Ben Bikman shares a short post tagged around GLP-1 drugs, metabolism and low carb diets. Little detail beyond the tags.
Loading…